// App-Quantinova.ai

39IN : WILL CIRCULATING BIOMARKERS HELP TO DELIVER PRECISION MEDICINE?

Researchers

Presenter

  • D. Olmos

Principal Investigators

  • E. CASTRO

  • N. Romero

  • D. Morales-Pancorbo

Medical Centers

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Urology

Disease

  • Prostate cancer

  • Acquired pure red cell aplasia

Biomarkers

  • Androgen receptor variant 7

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

  • Insulin-like growth factor 1 receptor

  • Plasma cell-free DNA

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved